| |
| Magyar Hypertonia Társaság |
|
| IV. Hypertonia Nap |
 Rendezvény kezdete: 2007.01.20. | Rendezvény vége: 2007.01.20. |
| Tudományos információ: Dr. Páll Dénes egyetemi adjunktus |
| Munkahely neve: DE OEC I. sz. Belklinika |
| Címe: 4012 Debrecen, Nagyerdei krt. 98. Pf. 19. |
| Tel: 52/414-227, 30/9-657-913 |
| E-mail: pall@internal.med.unideb.hu |
| Szervező: Magyar Hypertonia Társaság, Debreceni Egyetem OEC I. sz. Belgyógyászati Klinika Regionális Hypertonia Centrum, Családorvosi Tanszék |
| Helyszín: Debreceni Egyetem Központi Épület, Aula |
|
|
 |
| |
| Magyar Immunológiai Társaság |
|
| Cross-Border Healthcare in Europe: |
| Rendezvény kezdete: 2013.02.26. | Rendezvény vége: 2013.02.26. |
| Helyszín: Belgium, Brussels, The Silken Berlaymont Hotel |
| A rendezvény Web oldala: http://publicpolicyexchange.co.uk/events/DB26-PPE2.php |
Cross-Border Healthcare in Europe:
Removing the Barriers to Deliver Clarity and Quality
The EU Directive on Patients’ Rights in Cross-Border Healthcare seeks to eliminate obstacles hindering patients from receiving treatment in another Member State. Rules for receiving cross-border healthcare and reimbursement of these costs are not always clear and, as such, the Directive provides more transparency and also clarifies who is responsible for quality and safety of care in cross-border settings.
This timely international symposium will tackle challenges to the implementation of cross-border healthcare and its impact on patient safety and quality, health professionals’ mobility and European standards for healthcare services.
|
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| Cross-Border Healthcare in Europe: |
| Rendezvény kezdete: 2013.02.26. | Rendezvény vége: 2013.02.26. |
| Helyszín: Belgium, Brussels, The Silken Berlaymont Hotel |
| A rendezvény Web oldala: http://publicpolicyexchange.co.uk/events/DB26-PPE2.php |
Cross-Border Healthcare in Europe:
Removing the Barriers to Deliver Clarity and Quality
The EU Directive on Patients’ Rights in Cross-Border Healthcare seeks to eliminate obstacles hindering patients from receiving treatment in another Member State. Rules for receiving cross-border healthcare and reimbursement of these costs are not always clear and, as such, the Directive provides more transparency and also clarifies who is responsible for quality and safety of care in cross-border settings.
This timely international symposium will tackle challenges to the implementation of cross-border healthcare and its impact on patient safety and quality, health professionals’ mobility and European standards for healthcare services.
|
|
|
|
| |
| Magyar Diabetes Társaság |
|
| The 2nd International Conference on Prehypertension and Cardio Metabolic Syndrome |
| Rendezvény kezdete: 2013.01.31. | Rendezvény vége: 2013.02.03. |
| Szakterület(ek): Belgyógyászat |
| Munkahely neve: Paragon Conventions |
| Tel: +41 22 533 0948 |
| Fax: +41 22 580 2953 |
| E-mail: secretariat@prehypertension.org |
| Helyszín: Spanyolország, 08028 Barcelona, Av. Diagonal 661-671, Hotel Rey Juan Carlos I - Business & City Resort |
| A rendezvény Web oldala: http://www.prehypertension.org/ |
List of Topics
• Metabolic Syndrome and Vitamin D
• Prediabetes - Mechanisms, Diagnosis and Management
• Pre Levels of CV Risk Factors - Boosting Risk of Events and Deciding Who Should be Treated
• Benefits of Achieving Optimal Risk Factors Level - When, How and with What?
• Prehypertension and Metabolic Syndrome in Different Populations - Epidemiologic Aspects
• Total Cardiovascular Risk Evaluation and Management
• Arterial Properties, Evaluation and Treatment in Metabolic Syndrome
• Cardiac Markers of Preclinical Disease in Metabolic Syndrome Patients
• Effect of Pre Disease Risk Factors in Patients with the Metabolic Syndrome on Morbidity and Mortality
• Which Elderly Patients with Pre Disease should be Considered for Medical Treatment
• Children and Adolescents: Prehypertension and Metabolic Syndrome, Progression of Risk and Diagnosis of Disease
• The Heart, the Brain and the Kidney in Pre Disease and the Metabolic Syndrome
• Addressing the Global CV Risk Factors in Pre Disease and in Disease
• Arterial Properties, Central Blood Pressure and Augmentation Index in Pre Disease and Disease in Patients with Cardiometabolic Syndrome
• Prehypertension, Hypertension and Renal Denervation
• Prehypertension, Pre Diabetes and Dyslipidemia - Estimation of Risk and Therapeutic Approach
Important DatesDeadline for submission of abstracts: September 13, 2012
Deadline for early bird registration: October 15, 2012
Deadline for pre-conference registration: January 22, 2013 |
|
|
|
| |
| Magyar Nephrologiai Társaság |
|
| 2nd International Conference on Prehypertension and Cardio Metabolic Syndrome |
| Rendezvény kezdete: 2013.01.31. | Rendezvény vége: 2013.02.03. |
| Szakterület(ek): Nephrologia |
| Helyszín: Spain, Barcelona, |
| A rendezvény Web oldala: http://www.prehypertension.org |
| The Conference will aim to deal with all aspects related to early diagnosis, including innovative technologies and treatments, as well as bringing together professionals from the fields of Hypertension, Diabetes, Lipidology, Cardiology, Nephrology, Endocrinology, Internal Medicine, Pharmacology and more. |
|
|
|
| |
| Magyar Dermatológiai Társulat |
|
| 1st European School of Dermato-Oncology (EADO) |
| Rendezvény kezdete: 2013.01.17. | Rendezvény vége: 2013.01.19. |
| Szakterület(ek): Bőrgyógyászat |
| Helyszín: Germany, 10117 Berlin, NH Berlin Friedrichstrasse, NH Berlin Friedrichstrasse |
| A rendezvény Web oldala: http://www.dermato-oncology2013.com/ |
The EADO initiates a course dedicated to fundamentals in skin cancer targeted to specialists and residents in the final phase of their resident program. They will benefit a comprehensive and updated course to improve their decision-making process for the management of all types and stages of skin cancer, from diagnosis, primary treatment and adjuvant treatment, to the management of loco-regional disease and distant metastatic disease. It is intended to organize this course every year in different countries.
Target Audience
This 2,5-day educational course targets doctors who are actively involved in the treatment of skin cancer. Dermatologists or other specialists who have completed specialist training, or residents in the final year of their training program, are likely to gain the most from this course.
The maximum number of delegates is 100. In order to make the course available throughout Europe, places will be made available on a first come first served basis to all applicants.
|
|
|
|
